pillbase.ru

Gattex

Active substance: teduglutide

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · TEDUGLUTIDE 5 mg/.5mL

United StatesActive

Marketing holder: Takeda Pharmaceuticals America, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 2
  • Revestive
    teduglutide
    EMEA/H/C/002345
    Takeda Pharmaceuticals International AG Ireland
  • Teduglutide Viatris
    teduglutide
    EMEA/H/C/006564
    Viatris Limited
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-9496-79af-97eb-72141129bf15,01a12094-8497-7baa-bf34-e0c0174fa89d,01a12094-849f-70a8-9f9c-3e63e73e1857;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
68875-0101
Registration status
Active
Dispensing
Prescription only
Route
SUBCUTANEOUS
Sources
  • product · openFDA NDC · 68875-0101 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 68875-0101 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 68875-0101 · Verified 2026-10-09 · open in source